Earnings History Data for ReShape Lifesciences, Inc. (RSLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ReShape Lifesciences, Inc.

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2023	AH		RSLS	ReShape Lifesciences, Inc.	0.82	-1.02	0.00	-10.50	ReShape Lifesciences reports Q3 results [11/8/2023 5:45 PM]	0.2346	-0.02 (-7.60%)	0.24	-0.01 (-5.47%)	0.19 - 22.40	1,238,862	1,780,000	76,809
ReShape Lifesciences reports Q3 results [11/8/2023 5:45 PM]
15-05-2023	AH	After the close (May 15)	RSLS	ReShape Lifesciences, Inc.	4.32	-1.56	0.00	21.00	ReShape Lifesciences reports Q1 results [5/15/2023 4:20 PM]	2.30	-0.16 (-6.50%)	2.43	-0.03 (-1.22%)	2.21 - 52.50	75,270	100,000	2,965
ReShape Lifesciences reports Q1 results [5/15/2023 4:20 PM]
14-11-2022	PM	0:00 AM ET (Nov 14)	RSLS	ReShape Lifesciences, Inc.	3.50	-0.21	0.00	-1.20	ReShape Lifesciences reports Q3 results [11/14/2022 7:37 AM]	0.24	0.01 (3.18%)	0.25	0.01 (6.19%)	0.20 - 2.33	257,621	180,000	12,257
ReShape Lifesciences reports Q3 results [11/14/2022 7:37 AM] ReShape Lifesciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-14-22 07:30AM]
23-05-2022	PM	0:00 AM ET (May 23)	RSLS	ReShape Lifesciences, Inc.	15.48	-0.42	0.00	-1.32	ReShape Lifesciences GAAP EPS of -$0.44 misses by $0.10, revenue of $2.44M misses by $0.78M [5/23/2022 8:02 AM]	0.8015	-0.01 (-1.78%)	0.81	-0.01 (-0.74%)	0.65 - 14.64	39,520	70,000	4,884
ReShape Lifesciences GAAP EPS of -$0.44 misses by $0.10, revenue of $2.44M misses by $0.78M [5/23/2022 8:02 AM] ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-23-22 08:00AM]
28-03-2022	AH	0:00 AM ET (Mar 28)	RSLS	ReShape Lifesciences, Inc.	20.28	0.05	0.00	-0.51	ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M [3/28/2022 4:11 PM]	1.37	0.02 (1.33%)	1.52	0.17 (12.59%)	0.83 - 14.64	520,982	260,000	69,633
ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M [3/28/2022 4:11 PM] ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update [Mar-28-22 04:05PM]
11-11-2021	PM	Before the open (Nov 11)	RSLS	ReShape Lifesciences, Inc.	42.30	-1.20	0.00	-0.60	ReShape Lifesciences reports Q3 results [11/11/2021 8:54 AM]	2.47	-0.05 (-2.17%)	2.52	-0.01 (-0.40%)	2.38 - 32.31	901,453	440,000	73,365
ReShape Lifesciences reports Q3 results [11/11/2021 8:54 AM] ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results [Nov-11-21 08:30AM]
05-08-2021	PM		RSLS	ReShape Lifesciences, Inc.	58.93	N/A	0.00	-1.62	ReShape Lifesciences reports Q2 results [8/5/2021 8:47 AM]	3.85	0.25 (6.89%)	3.99	0.39 (10.83%)	2.13 - 32.31	3,878,720	3,240,000	2,082,133
ReShape Lifesciences reports Q2 results [8/5/2021 8:47 AM] ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update [Aug-05-21 08:00AM]